Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Neurol India ; 70(3): 1285-1286, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35864693

RESUMO

Diplopia, or double vision, is a symptom resulting from the perception of two images of a single object. We report a case of a possible silodosin-induced diplopia never reported before in the literature. We suggest that binocular diplopia should be considered in people assuming silodosin even if further studies should be conducted to explore possible pathogenetic mechanisms.


Assuntos
Diplopia , Visão Binocular , Diplopia/induzido quimicamente , Diplopia/diagnóstico , Humanos , Indóis
3.
Neurol Sci ; 41(12): 3767-3768, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-32719902

RESUMO

Coronavirus disease 2019 (COVID-19) infection has the potential for targeting the central nervous system, and several neurological symptoms have been reported in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We describe a 48-year-old Caucasian woman with SARS-CoV-2 infection followed by the onset of word finding difficulties, effortful speech along with prosody distortion, in the context of spared semantic and syntactic abilities. The clinical picture, perceived as foreign accent syndrome (FAS), was not associated with structural and functional imaging changes or neurophysiological assessment abnormalities. We suggest that FAS, herein perceived as a regional accent syndrome, should be considered a possible additional neurological manifestation of SARS-CoV-2.


Assuntos
Infecções por Coronavirus/complicações , Pneumonia Viral/complicações , Distúrbios da Fala/virologia , Betacoronavirus , COVID-19 , Feminino , Humanos , Pessoa de Meia-Idade , Pandemias , SARS-CoV-2
5.
Clin Chem Lab Med ; 58(7): 1100-1105, 2020 06 25.
Artigo em Inglês | MEDLINE | ID: mdl-32573995

RESUMO

Background Comprehensive information has been published on laboratory tests which may predict worse outcome in Asian populations with coronavirus disease 2019 (COVID-19). The aim of this study is to describe laboratory findings in a group of Italian COVID-19 patients in the area of Valcamonica, and correlate abnormalities with disease severity. Methods The final study population consisted of 144 patients diagnosed with COVID-19 (70 who died during hospital stay and 74 who survived and could be discharged) between March 1 and 30, 2020, in Valcamonica Hospital. Demographical, clinical and laboratory data were collected upon hospital admission and were then correlated with outcome (i.e. in-hospital death vs. discharge). Results Compared to patients who could be finally discharged, those who died during hospital stay displayed significantly higher values of serum glucose, aspartate aminotransferase (AST), creatine kinase (CK), lactate dehydrogenase (LDH), urea, creatinine, high-sensitivity cardiac troponin I (hscTnI), prothrombin time/international normalized ratio (PT/INR), activated partial thromboplastin time (APTT), D-dimer, C reactive protein (CRP), ferritin and leukocytes (especially neutrophils), whilst values of albumin, hemoglobin and lymphocytes were significantly decreased. In multiple regression analysis, LDH, CRP, neutrophils, lymphocytes, albumin, APTT and age remained significant predictors of in-hospital death. A regression model incorporating these variables explained 80% of overall variance of in-hospital death. Conclusions The most important laboratory abnormalities described here in a subset of European COVID-19 patients residing in Valcamonica are highly predictive of in-hospital death and may be useful for guiding risk assessment and clinical decision-making.


Assuntos
Infecções por Coronavirus/diagnóstico , Infecções por Coronavirus/mortalidade , Pneumonia Viral/diagnóstico , Pneumonia Viral/mortalidade , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Arginina/sangue , Aspartato Aminotransferases/sangue , Betacoronavirus , Glicemia/análise , Proteína C-Reativa/análise , COVID-19 , Teste para COVID-19 , Carnosina/sangue , Técnicas de Laboratório Clínico , Comorbidade , Infecções por Coronavirus/fisiopatologia , Creatina Quinase/sangue , Creatinina/sangue , Combinação de Medicamentos , Feminino , Ferritinas/sangue , Produtos de Degradação da Fibrina e do Fibrinogênio , Mortalidade Hospitalar , Humanos , Itália , L-Lactato Desidrogenase/sangue , Leucócitos , Linfócitos , Masculino , Pessoa de Meia-Idade , Neutrófilos , Pandemias , Tempo de Tromboplastina Parcial , Pneumonia Viral/fisiopatologia , Tempo de Protrombina , SARS-CoV-2 , Albumina Sérica Humana/análise , Troponina I/sangue , Ureia/sangue
6.
J Neurol Sci ; 278(1-2): 64-5, 2009 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-19084843

RESUMO

Topiramate (TPM) is generally recognized efficacious and safe in migraine prevention. A significant proportion of patients undergoing TPM administration may show weight loss. In epileptic subjects, high body mass index (BMI) was found to be predictive of weight loss under TPM therapy. We therefore aimed to study whether common clinical determinants may be associated to TPM weigh loss in migraine patients. In our clinical series, high BMI was not found a predictor of weight loss under TPM treatment. Unknown genetic and environmental factors that may determine the courses of weight loss under TPM therapy are still do be identified.


Assuntos
Frutose/análogos & derivados , Transtornos de Enxaqueca/tratamento farmacológico , Redução de Peso/efeitos dos fármacos , Adulto , Índice de Massa Corporal , Feminino , Frutose/uso terapêutico , Humanos , Modelos Lineares , Masculino , Transtornos de Enxaqueca/fisiopatologia , Estudos Prospectivos , Topiramato
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...